Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conversion Disorder | 4 | 2021 | 205 | 1.280 |
Why?
|
| Brain | 21 | 2022 | 26345 | 0.750 |
Why?
|
| Nerve Net | 7 | 2021 | 2173 | 0.700 |
Why?
|
| Endophenotypes | 1 | 2020 | 250 | 0.620 |
Why?
|
| Diffusion Tensor Imaging | 5 | 2020 | 2305 | 0.600 |
Why?
|
| Myotonic Dystrophy | 3 | 2021 | 78 | 0.540 |
Why?
|
| Nervous System Diseases | 3 | 2021 | 1619 | 0.510 |
Why?
|
| Motor Cortex | 2 | 2020 | 986 | 0.500 |
Why?
|
| Amygdala | 2 | 2020 | 1313 | 0.490 |
Why?
|
| Cerebral Cortex | 6 | 2022 | 5692 | 0.410 |
Why?
|
| tau Proteins | 5 | 2022 | 1869 | 0.410 |
Why?
|
| Brain Mapping | 8 | 2021 | 6622 | 0.310 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2022 | 35409 | 0.280 |
Why?
|
| Visual Cortex | 3 | 2020 | 1136 | 0.260 |
Why?
|
| Cognition | 2 | 2019 | 6759 | 0.240 |
Why?
|
| Executive Function | 3 | 2021 | 1361 | 0.220 |
Why?
|
| Alzheimer Disease | 6 | 2022 | 8035 | 0.220 |
Why?
|
| Dissociative Disorders | 2 | 2022 | 231 | 0.210 |
Why?
|
| Neuronal Plasticity | 3 | 2021 | 1420 | 0.210 |
Why?
|
| Anticipation, Psychological | 1 | 2020 | 87 | 0.180 |
Why?
|
| Neural Pathways | 3 | 2019 | 2971 | 0.180 |
Why?
|
| Stuttering | 1 | 2019 | 25 | 0.180 |
Why?
|
| Dystrophin | 1 | 2021 | 285 | 0.180 |
Why?
|
| Synaptic Vesicles | 1 | 2021 | 191 | 0.180 |
Why?
|
| Investments | 1 | 2021 | 143 | 0.170 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2021 | 422 | 0.170 |
Why?
|
| Amyloid beta-Peptides | 3 | 2022 | 3587 | 0.170 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2018 | 59 | 0.160 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2021 | 544 | 0.160 |
Why?
|
| Putamen | 1 | 2019 | 291 | 0.150 |
Why?
|
| Neurofilament Proteins | 1 | 2019 | 318 | 0.150 |
Why?
|
| Pain Threshold | 1 | 2021 | 584 | 0.150 |
Why?
|
| T-Box Domain Proteins | 1 | 2020 | 471 | 0.150 |
Why?
|
| Multiple Organ Failure | 1 | 2019 | 389 | 0.150 |
Why?
|
| Movement Disorders | 1 | 2020 | 448 | 0.150 |
Why?
|
| Aging | 3 | 2021 | 8655 | 0.150 |
Why?
|
| Semantics | 1 | 2020 | 585 | 0.150 |
Why?
|
| Long-Term Potentiation | 1 | 2018 | 293 | 0.140 |
Why?
|
| Nucleus Accumbens | 1 | 2019 | 366 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2020 | 1142 | 0.140 |
Why?
|
| Calcium Channels | 1 | 2020 | 622 | 0.140 |
Why?
|
| Positron-Emission Tomography | 3 | 2022 | 6237 | 0.130 |
Why?
|
| Membrane Potentials | 1 | 2019 | 1137 | 0.130 |
Why?
|
| Corpus Callosum | 1 | 2019 | 736 | 0.130 |
Why?
|
| Lysosomes | 1 | 2019 | 893 | 0.120 |
Why?
|
| Adult | 18 | 2021 | 213889 | 0.120 |
Why?
|
| Dopamine | 1 | 2021 | 1592 | 0.120 |
Why?
|
| Cortical Spreading Depression | 1 | 2017 | 276 | 0.110 |
Why?
|
| Social Behavior | 1 | 2020 | 1126 | 0.110 |
Why?
|
| Space Perception | 1 | 2016 | 474 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 21733 | 0.110 |
Why?
|
| Somatosensory Cortex | 1 | 2017 | 525 | 0.110 |
Why?
|
| Humans | 35 | 2022 | 743811 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2016 | 1723 | 0.110 |
Why?
|
| Blindness | 1 | 2017 | 612 | 0.110 |
Why?
|
| Gyrus Cinguli | 1 | 2019 | 1091 | 0.110 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 1940 | 0.110 |
Why?
|
| Male | 21 | 2021 | 349776 | 0.110 |
Why?
|
| Psychomotor Performance | 2 | 2020 | 1895 | 0.100 |
Why?
|
| Thalamus | 1 | 2018 | 1023 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 935 | 0.100 |
Why?
|
| Visual Pathways | 1 | 2016 | 558 | 0.100 |
Why?
|
| Corpus Striatum | 1 | 2018 | 1219 | 0.100 |
Why?
|
| Visual Perception | 2 | 2020 | 1414 | 0.100 |
Why?
|
| DNA Primers | 1 | 2016 | 2891 | 0.100 |
Why?
|
| Female | 21 | 2021 | 380020 | 0.100 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 1793 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 1060 | 0.100 |
Why?
|
| Rest | 1 | 2015 | 901 | 0.090 |
Why?
|
| Models, Biological | 2 | 2018 | 9582 | 0.090 |
Why?
|
| Hippocampus | 2 | 2020 | 3672 | 0.090 |
Why?
|
| Young Adult | 8 | 2021 | 56392 | 0.090 |
Why?
|
| Gene Expression | 2 | 2020 | 7793 | 0.090 |
Why?
|
| Seizures | 1 | 2022 | 2850 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 9440 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2015 | 2712 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2785 | 0.080 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 2147 | 0.080 |
Why?
|
| Middle Aged | 13 | 2021 | 213241 | 0.070 |
Why?
|
| Decision Making | 1 | 2021 | 3887 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6170 | 0.070 |
Why?
|
| Pain | 1 | 2021 | 4987 | 0.070 |
Why?
|
| Atrophy | 2 | 2020 | 1577 | 0.060 |
Why?
|
| Proteins | 1 | 2020 | 6098 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4463 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 12066 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2016 | 3079 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12243 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15526 | 0.050 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2019 | 34 | 0.050 |
Why?
|
| Neurofibrillary Tangles | 1 | 2022 | 439 | 0.040 |
Why?
|
| Pain Perception | 1 | 2021 | 191 | 0.040 |
Why?
|
| Child | 4 | 2021 | 77637 | 0.040 |
Why?
|
| Prader-Willi Syndrome | 1 | 2020 | 79 | 0.040 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2020 | 80 | 0.040 |
Why?
|
| Aged | 7 | 2021 | 163178 | 0.040 |
Why?
|
| Presenilin-1 | 1 | 2022 | 635 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2019 | 237 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2019 | 243 | 0.040 |
Why?
|
| Individuality | 1 | 2019 | 307 | 0.040 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2016 | 17 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 1436 | 0.040 |
Why?
|
| Anisotropy | 1 | 2019 | 1263 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2021 | 1079 | 0.030 |
Why?
|
| Heterozygote | 1 | 2022 | 2803 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2022 | 1186 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2019 | 1340 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 25032 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 8939 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2021 | 1358 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 29777 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2021 | 3420 | 0.020 |
Why?
|
| Plasmids | 1 | 2016 | 2308 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 57744 | 0.020 |
Why?
|
| Synapses | 1 | 2020 | 1728 | 0.020 |
Why?
|
| Memory | 1 | 2020 | 2173 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1885 | 0.020 |
Why?
|
| Heart Rate | 1 | 2020 | 4091 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 6976 | 0.020 |
Why?
|
| Adolescent | 3 | 2021 | 85729 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9731 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 3320 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8316 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2016 | 4216 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13273 | 0.010 |
Why?
|
| Software | 1 | 2016 | 4440 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2019 | 4266 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18355 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39001 | 0.010 |
Why?
|
| Quality of Life | 1 | 2019 | 12788 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 40545 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 77410 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 168660 | 0.000 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_